BIOLIFE SOLUTIONS INC (BLFS) Stock

HealthcareMedical Instruments & Supplies Website

2 members of Congress disclosed 4 trades in BLFS since 2020: 3 purchases and 1 sale, most recently Christopher L. Jacobs (sale, Dec 12, 2022).

Which members of Congress traded BIOLIFE SOLUTIONS INC (BLFS)?

Members
2
Disclosed trades
4
Purchases
3
Sales
1

Most recent: Christopher L. Jacobs (sale, Dec 12, 2022); records start Jun 17, 2020.

PoliticianTrade dateTypeAmount
Chris Jacobs
R-NY · House
2022-12-12sale$1k – $15k
Chris Jacobs
R-NY · House
2022-11-08purchase$1k – $15k
Tom Malinowski
D-NJ · House
2020-07-07purchase$1k – $15k
Tom Malinowski
D-NJ · House
2020-06-17purchase$15k – $50k

From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026.

See all BLFS political trades →

BLFS price chart

Powered by TradingView

What does BIOLIFE SOLUTIONS INC do?

Biolife Solutions Inc. is a leading provider of cell and gene therapy bioproduction tools and services. It specializes in offering biopreservation media, automated thawing devices, and storage solutions that are essential for preserving and transporting biological materials. The company's products help enhance the quality and stability of biological samples, which is crucial in sectors like regenerative medicine, biobanking, and drug discovery. By ensuring the safe handling and preservation of cells, tissues, and organs, Biolife Solutions plays a pivotal role in supporting life science research and clinical applications. The company's innovations contribute significantly to advancing therapeutic research and the development of treatments, thereby impacting the healthcare industry extensively. Headquartered in Bothell, Washington, Biolife Solutions Inc. is strategically positioned in the market, facilitating the evolving needs of the biopharmaceutical sector worldwide.

CEO
Mr. Roderick de Greef
Employees
159
Ask about BLFSAI research agent